Endeavor Health is studying Exact Sciences’ Cancerguard blood test to help see if multi-cancer detection should be deployed widely across hospitals. The five-year study aims to fill gaps in real-world evidence on how these tests perform and how they fit into routine healthcare.
Color Health is partnering with insurer Evry Health to offer its virtual cancer clinic to employer health plan members.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Curious medical experts can compare the best employers at the top-rated hospitals for cancer treatment in Pennsylvania to provide excellent patient care in a supportive environment.
Tampa General Hospital is launching a virtual cancer care program with Reimagine Care. The partnership seeks to support cancer patients between visits and reduce avoidable emergency care, as well as reduce oncologists’ administrative burden.
New tools can predict deadly reactions to common cancer drugs, but adoption lags despite evidence.
We know that exercise is medicine. The science is clear, the mechanisms are known, and the tools are available to deliver it safely. To make all that mean something for patients, cancer care must evolve to include movement as a standard element of every stage of the journey, not as a wellness option, but as a clinical necessity.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Theranostics — which combines molecular imaging with targeted therapy — is quickly becoming a significant innovation in cancer care, offering more precise treatment with fewer side effects. GE Healthcare expects the field to grow rapidly over the next decade, as long as hospitals can continue to invest in the imaging and software infrastructure needed to scale these therapies.
This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources.
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher.
Memorial Hermann Health System and Moffitt Cancer Center have recently struck partnerships with Reimagine Care, a startup focused on providing support to cancer patients via an AI assistant and text messages with oncology experts.
Alan Murray on improving access for medical transportation.
Thyme Care's Series C funding round includes investments from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital.
It is critical that we rightsize and redistribute available funds based on our knowledge of persistent cancer disparities to help more patients benefit from potentially lifesaving innovations and ensure no one is left behind.
Access to oncology-specific interdisciplinary care delivered digitally by a team of nurses, mental health therapists, nutritionists, advanced practice providers, and oncologists is the best option for combatting pain points related to both cost and access.
Immune checkpoint inhibitors are effective cancer treatments, but are expensive. Understanding the least-costly settings for administering treatments, leveraging genomic testing and following evidence-based guidelines can help health plans optimize cancer care, according to Evernorth Research Institute.
Carrum Health's $45 million funding round was led by OMERS Growth Equity and included participation from Revelation Partners, Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. It brings the company’s total financing to about $96 million.